Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Programs Update

Go back to Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Programs Update

Tonix Pharma (TNXP) Reports Q4 Loss of $2.08/Share

April 17, 2017 7:15 AM EDT

Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($2.08), versus ($7.96) reported last year.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

... More